Tsuyoshi Fujita to Treatment Outcome
This is a "connection" page, showing publications Tsuyoshi Fujita has written about Treatment Outcome.
Connection Strength
0.079
-
Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol. 2017 Mar 21; 23(11):2060-2067.
Score: 0.024
-
Takeuchi T, Ota K, Harada S, Kojima Y, Inoue T, Iwakiri R, Sakata Y, Fujimoto K, Fujita T, Azuma T, Higuchi K. Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin. J Gastroenterol Hepatol. 2014 Dec; 29 Suppl 4:11-5.
Score: 0.020
-
Toyonaga T, Man-i M, East JE, Nishino E, Ono W, Hirooka T, Ueda C, Iwata Y, Sugiyama T, Dozaiku T, Hirooka T, Fujita T, Inokuchi H, Azuma T. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013 Mar; 27(3):1000-8.
Score: 0.018
-
Man-i M, Morita Y, Fujita T, East JE, Tanaka S, Wakahara C, Yoshida M, Hayakumo T, Kutsumi H, Inokuchi H, Toyonaga T, Azuma T. Endoscopic submucosal dissection for gastric neoplasm in patients with co-morbidities categorized according to the ASA Physical Status Classification. Gastric Cancer. 2013 Jan; 16(1):56-66.
Score: 0.017